Windtree Therapeutics announces 1-for-50 reverse stock split effective Feb 20, 2025

WINDTREE THERAPEUTICS INC /DE/

Reverse stock split approved by stockholders on Feb 3, 2025; ratio set at 1-for-50.
Effective at 5:00 p.m. ET on Feb 20, 2025; adjusted trading begins Feb 21 under ticker WINT.
Aimed at meeting Nasdaq $1.00 minimum bid price requirement; new CUSIP: 97382D600.
Post-split outstanding shares reduced to approximately 700,000; no fractional shares issued.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.